You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Acitretin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for acitretin and what is the scope of patent protection?

Acitretin is the generic ingredient in two branded drugs marketed by Alembic, Barr Labs Inc, Impax Labs Inc, Mylan, Norvium Bioscience, Sigmapharm Labs Llc, Teva Pharms Usa, and Stiefel Labs Inc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for acitretin. Eight suppliers are listed for this compound.

Summary for acitretin
Drug Prices for acitretin

See drug prices for acitretin

Recent Clinical Trials for acitretin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Singapore General HospitalPhase 4
Translational Immunology InstitutePhase 4
South Valley UniversityPhase 4

See all acitretin clinical trials

Pharmacology for acitretin
Drug ClassRetinoid
Medical Subject Heading (MeSH) Categories for acitretin

US Patents and Regulatory Information for acitretin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan ACITRETIN acitretin CAPSULE;ORAL 202148-001 Sep 10, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-004 Dec 23, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-001 Dec 23, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc ACITRETIN acitretin CAPSULE;ORAL 202552-003 Dec 23, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.